These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15630137)

  • 1. NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production.
    Kim HY; Kim HJ; Min HS; Kim S; Park WS; Park SH; Chung DH
    J Exp Med; 2005 Jan; 201(1):41-7. PubMed ID: 15630137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12p35 promotes antibody-induced joint inflammation by activating NKT cells and suppressing TGF-beta.
    Park Y; Kim HS; Ahn JY; Yun D; Cho ML; Hong S; Kim HY; Chung DH
    J Immunol; 2010 Aug; 185(3):1476-84. PubMed ID: 20581146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FcgammaRIII engagement provides activating signals to NKT cells in antibody-induced joint inflammation.
    Kim HY; Kim S; Chung DH
    J Clin Invest; 2006 Sep; 116(9):2484-92. PubMed ID: 16917543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
    Bharhani MS; Chiu B; Na KS; Inman RD
    Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma.
    Kim JH; Kim HY; Kim S; Chung JH; Park WS; Chung DH
    Am J Pathol; 2005 Nov; 167(5):1231-41. PubMed ID: 16251408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis.
    Kaieda S; Tomi C; Oki S; Yamamura T; Miyake S
    Arthritis Rheum; 2007 Jun; 56(6):1836-45. PubMed ID: 17530712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide.
    Chiba A; Oki S; Miyamoto K; Hashimoto H; Yamamura T; Miyake S
    Arthritis Rheum; 2004 Jan; 50(1):305-13. PubMed ID: 14730629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1d-restricted IFN-γ-secreting NKT cells promote immune complex-induced acute lung injury by regulating macrophage-inflammatory protein-1α production and activation of macrophages and dendritic cells.
    Kim JH; Chung DH
    J Immunol; 2011 Feb; 186(3):1432-41. PubMed ID: 21191075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide.
    Morishima Y; Ishii Y; Kimura T; Shibuya A; Shibuya K; Hegab AE; Iizuka T; Kiwamoto T; Matsuno Y; Sakamoto T; Nomura A; Taniguchi M; Sekizawa K
    Eur J Immunol; 2005 Oct; 35(10):2803-14. PubMed ID: 16163669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice deficient in Vbeta8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction.
    Habu Y; Shinomiya N; Kinoshita M; Matsumoto A; Kawabata T; Seki S
    Clin Exp Med; 2007 Mar; 7(1):30-8. PubMed ID: 17380303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM; Palmer JL; Gamelli RL; Faunce DE
    Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T
    Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
    Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
    Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine models.
    Chiba A; Kaieda S; Oki S; Yamamura T; Miyake S
    Arthritis Rheum; 2005 Jun; 52(6):1941-8. PubMed ID: 15934073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity.
    Lee KA; Kang MH; Lee YS; Kim YJ; Kim DH; Ko HJ; Kang CY
    Cell Immunol; 2008 Jan; 251(1):50-5. PubMed ID: 18423430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
    Kuwatani M; Ikarashi Y; Iizuka A; Kawakami C; Quinn G; Heike Y; Yoshida M; Asaka M; Takaue Y; Wakasugi H
    Immunol Lett; 2006 Jul; 106(1):82-90. PubMed ID: 16806496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K; Exley MA; Jiang X; Ohkochi N; Taniguchi M; Seino K
    Cancer Res; 2006 Dec; 66(23):11441-6. PubMed ID: 17145891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Repeated administration of alpha-galactosyl ceramide attenuates of natural killer T cells].
    Minagawa M; Iiai T; Sato Y; Yamamoto S; Hatakeyama K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1553-5. PubMed ID: 16315866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the activation profile of dendritic cells derived from the bone marrow of interleukin-12/interleukin-23-deficient mice.
    Bastos KR; de Deus Vieira de Moraes L; Zago CA; Marinho CR; Russo M; Alvarez JM; D'Império Lima MR
    Immunology; 2005 Apr; 114(4):499-506. PubMed ID: 15804287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma.
    Furlan R; Bergami A; Cantarella D; Brambilla E; Taniguchi M; Dellabona P; Casorati G; Martino G
    Eur J Immunol; 2003 Jul; 33(7):1830-8. PubMed ID: 12811843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.